CHUGAI PHARMACEUTICAL CO.,LTD.

4519

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-07-24FY2026 Q2

Revenue

1.34T JPY

YoY +12.3%

Operating Income

3196.2100M JPY

YoY +16.9%

Net Income

4713.7100M JPY

YoY +19.2%

EPS

140.8JPY

YoY +19.2%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

1.3兆円

9449.6億円

6299.7億円

3149.9億円

Rev: 9997.6億円Op: 4219億円NI: 3029.9億円

Rev: 1.3兆円Op: 5333.1億円NI: 3744.3億円

Rev: 1.1兆円Op: 4391.7億円NI: 3254.7億円

Rev: 1.2兆円Op: 5420億円NI: 3873.2億円

Rev: 1.3兆円Op: 5988.3億円NI: 4340.1億円

2021/FY2022/FY2023/FY2024/FY2025/FY

Full-Year Progress

FY2026 Q2

Net Income-

Revenue Progress6633.300M

Revenue Forecast-

Net Income Progress2317.500M

Net Income Forecast-

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan